Boill Healthcare Holdings Limited (Stock Code: 01246) submitted its monthly return for the period ended 31 October 2025 on 26 January 2026. According to the announcement, the company’s authorised share capital remains at 4,800,000,000 ordinary shares with a par value of HKD 0.25, totaling HKD 1,200,000,000.

The number of issued ordinary shares was unchanged at 1,358,000,000, with no treasury shares recorded. The company confirmed it continued to meet the public float requirement, maintaining at least 25% of the total issued shares in public hands. No additional share issuance or repurchases were reported during the month.

Regarding share options under the scheme adopted on 27 September 2023, there was no exercise of options in October. The potential maximum number of shares issuable under outstanding options was stated as 135,800,000. No new shares were issued, and no funds were raised through the exercise of share options over the period.